Stout served as exclusive financial advisor to Ada Health in the extension of its Series B funding round to $120 million. The new funding will enable Ada to accelerate its growth and strengthen its presence in the U.S., following strong interest and traction in that market.

The extension was raised from international investors – U.S.-based Farallon Capital, cross-border investor Red River West and Bertelsmann Investments, German media company Bertelsmann’s international venture capital arm. This follows an initial Series B raise of $90 million last May, which was led by Leaps by Bayer, the impact investment arm of Bayer AG, with further investments from Vitruvian Partners, Inteligo Bank, F4, and Mutschler Ventures.

View the full news release.